- Registration Closed
This presentation will start off by exploring the nationwide landscape of NP practice, resistance/acceptance of full practice authority, and the predictable turning of “green” in all 50 states. This is followed by 5 -7 recommendations to enable NPs to thrive personally and professionally in their full practice authority (green) environment.
Credits: 1.00 contact hours; 0.00 are pharmacology
Release Date: November 19, 2021
End Date: November 19, 2022
$25.00
Learning Objectives
After taking part in this educational activity, participants should be better able to:
- Describe 3 examples of delayed acceptance of change even when it represents improvement in lifestyle.
- Understand how personal acceptance of innovation diffuses into human life.
- Develop 6 strategies that will facilitate personal/professional change for nurse practitioners.
Amelie Hollier, DNP, FNP-BC, FAANP
President, CEO
Advanced Practice Education Associates (APEA)
Dr. Amelie Hollier is a nurse practitioner in family practice in Lafayette, La. She has practiced as an APRN for the last 26 years.
She is President, CEO of Advanced Practice Education Associates (APEA), a nurse practitioner education company. She teaches nurse practitioner review courses across the United States for her company and routinely presents to nurse practitioner groups on pharmacology topics and clinical updates.
In the last 24 years, Amelie has authored, co-authored and edited 25 books for nurse practitioners and nurse practitioner students. Her Clinical Guidelines in Primary Care has been a national best seller. She is Editor in Chief of CareOnPoint, an evidence-based online reference tool for primary care providers. She completed her doctorate of nursing practice at the University of Tennessee in 2007 where her area of study was pharmacotherapeutics. Amelie was inducted as a Fellow in the American Academy of Nurse Practitioners in June 2007.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.00 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Amelie Hollier, DNP, FNP-BC, FAANP, have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.